• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球轮状病毒疾病在疫苗接种前年龄<5 岁儿童中的年龄分布综述。

Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.

机构信息

London School of Hygiene and Tropical Medicine, United Kingdom.

World Health Organization, Geneva, Switzerland.

出版信息

Clin Infect Dis. 2019 Aug 30;69(6):1071-1078. doi: 10.1093/cid/ciz060.

DOI:10.1093/cid/ciz060
PMID:30689799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6736387/
Abstract

We sought datasets with granular age distributions of rotavirus-positive disease presentations among children <5 years of age, before the introduction of rotavirus vaccines. We identified 117 datasets and fit parametric age distributions to each country dataset and mortality stratum. We calculated the median age and the cumulative proportion of rotavirus gastroenteritis events expected to occur at ages between birth and 5.0 years. The median age of rotavirus-positive hospital admissions was 38 weeks (interquartile range [IQR], 25-58 weeks) in countries with very high child mortality and 65 weeks (IQR, 40-107 weeks) in countries with very low or low child mortality. In countries with very high child mortality, 69% of rotavirus-positive admissions in children <5 years of age were in the first year of life, with 3% by 10 weeks, 8% by 15 weeks, and 27% by 26 weeks. This information is critical for assessing the potential benefits of alternative rotavirus vaccination schedules in different countries and for monitoring program impact.

摘要

我们寻找了在轮状病毒疫苗引入之前,有<5 岁儿童轮状病毒阳性疾病表现的详细年龄分布的数据集。我们确定了 117 个数据集,并为每个国家数据集和死亡率分层拟合了参数化年龄分布。我们计算了预期在出生至 5.0 岁之间发生的轮状病毒胃肠炎事件的中位数年龄和累积比例。在儿童死亡率非常高的国家,轮状病毒阳性住院的中位数年龄为 38 周(四分位距[IQR],25-58 周),在儿童死亡率非常低或低的国家,中位数年龄为 65 周(IQR,40-107 周)。在儿童死亡率非常高的国家,<5 岁的轮状病毒阳性住院患儿中有 69%发生在生命的第一年,10 周时有 3%,15 周时有 8%,26 周时有 27%。这些信息对于评估不同国家替代轮状病毒疫苗接种时间表的潜在收益以及监测计划的影响至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/ccfc541fba9b/ciz060f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/fd4d9bcad7ad/ciz060f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/34e9d1b22af7/ciz060f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/ccfc541fba9b/ciz060f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/fd4d9bcad7ad/ciz060f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/34e9d1b22af7/ciz060f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8d/6736387/ccfc541fba9b/ciz060f0003.jpg

相似文献

1
Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.全球轮状病毒疾病在疫苗接种前年龄<5 岁儿童中的年龄分布综述。
Clin Infect Dis. 2019 Aug 30;69(6):1071-1078. doi: 10.1093/cid/ciz060.
2
Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality From Diarrhea.轮状病毒疫苗对儿童腹泻住院率和死亡率的全球影响。
J Infect Dis. 2017 Jun 1;215(11):1666-1672. doi: 10.1093/infdis/jix186.
3
Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.轮状病毒疫苗纳入澳大利亚国家儿童免疫接种计划后,轮状病毒相关急性胃肠炎发病率降低。
Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee.
4
Rotavirus vaccines: update on global impact and future priorities.轮状病毒疫苗:全球影响及未来重点的最新情况
Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Epub 2011 Dec 1.
5
Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.马拉维婴儿单价轮状病毒疫苗接种的成本效益:一项使用个体患者层面成本核算数据的引入后分析
Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S220-8. doi: 10.1093/cid/civ1025.
6
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.美国针对儿童严重轮状病毒肠胃炎开展的基于人群的主动监测。
Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.
7
Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination.轮状病毒疫苗接种后对南澳大利亚儿童的轮状病毒阳性和所有病因胃肠炎住院的直接和间接影响。
Vaccine. 2011 Jun 24;29(29-30):4663-7. doi: 10.1016/j.vaccine.2011.04.109. Epub 2011 May 14.
8
Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana.轮状病毒疫苗对博茨瓦纳儿童肠胃炎住院率和死亡率的影响。
Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S168-74. doi: 10.1093/cid/civ1210.
9
Hospital bed occupancy for rotavirus and all cause acute gastroenteritis in two Finnish hospitals before and after the implementation of the national rotavirus vaccination program with RotaTeq®.在芬兰两家医院实施使用RotaTeq®的国家轮状病毒疫苗接种计划前后,轮状病毒及所有病因引起的急性胃肠炎的住院床位占用情况。
BMC Health Serv Res. 2014 Dec 11;14:632. doi: 10.1186/s12913-014-0632-z.
10
Disease Burden of Rotavirus Gastroenteritis in Children Residing in Germany: A Retrospective, Hospital-based Surveillance.德国儿童轮状病毒肠胃炎的疾病负担:一项基于医院的回顾性监测研究
Pediatr Infect Dis J. 2016 Jan;35(1):97-103. doi: 10.1097/INF.0000000000000939.

引用本文的文献

1
Cost-effectiveness and benefit-risk of rotavirus vaccination in Afghanistan: a modelling analysis informed by post-licensure surveillance.阿富汗轮状病毒疫苗接种的成本效益及利弊分析:一项基于上市后监测的模型分析
BMC Health Serv Res. 2025 Jul 4;25(1):926. doi: 10.1186/s12913-025-12885-5.
2
Indirect Effects of Universal Infant Rotavirus Vaccination: A Narrative Systematic Review.通用婴儿轮状病毒疫苗的间接影响:一项叙述性系统评价
Vaccines (Basel). 2025 May 9;13(5):503. doi: 10.3390/vaccines13050503.
3
Prevalence of Acute Gastroenteritis Enteropathogens Among Hospitalized Children in Jordan: A Single-Center Study.

本文引用的文献

1
Evaluation of a Booster Dose of Pentavalent Rotavirus Vaccine Coadministered With Measles, Yellow Fever, and Meningitis A Vaccines in 9-Month-Old Malian Infants.评价 9 月龄马里婴儿接种五价轮状病毒疫苗加强针与麻疹、黄热病和脑膜炎 A 联合疫苗的效果。
J Infect Dis. 2018 Jul 13;218(4):606-613. doi: 10.1093/infdis/jiy215.
2
Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.用于从出生起靶向轮状病毒的人新生儿轮状病毒疫苗(RV3-BB)。
N Engl J Med. 2018 Feb 22;378(8):719-730. doi: 10.1056/NEJMoa1706804.
3
Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality.
约旦住院儿童急性胃肠炎肠道病原体的流行情况:一项单中心研究
Viruses. 2025 Apr 30;17(5):657. doi: 10.3390/v17050657.
4
Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial.一种新型轮状病毒灭活疫苗在中国青少年人群中的安全性和免疫原性:一项随机、双盲、安慰剂对照的I期临床试验
Vaccines (Basel). 2025 Mar 30;13(4):369. doi: 10.3390/vaccines13040369.
5
Global estimates of rotavirus vaccine efficacy and effectiveness: a rapid review and meta-regression analysis.全球轮状病毒疫苗效力和效果的评估:一项快速综述与meta回归分析
EClinicalMedicine. 2025 Mar 4;81:103122. doi: 10.1016/j.eclinm.2025.103122. eCollection 2025 Mar.
6
Accounting for local incidence when estimating rotavirus vaccine efficacy among countries: a pooled analysis of monovalent rotavirus vaccine trials.在各国估计轮状病毒疫苗效力时考虑当地发病率:单价轮状病毒疫苗试验的汇总分析
Am J Epidemiol. 2024 Dec 26. doi: 10.1093/aje/kwae467.
7
Development of RT-dPCR method and reference material for rotavirus G3P8 and G9P8.轮状病毒G3P8和G9P8的逆转录数字PCR方法及参考物质的开发
Anal Bioanal Chem. 2025 May;417(12):2513-2523. doi: 10.1007/s00216-024-05690-2. Epub 2024 Dec 16.
8
The Planetary Child Health & Enterics Observatory (Plan-EO): A protocol for an interdisciplinary research initiative and web-based dashboard for mapping enteric infectious diseases and their risk factors and interventions in LMICs.行星儿童健康与肠道观察站(Plan-EO):一项跨学科研究计划和基于网络的仪表板协议,用于绘制中低收入国家肠道传染病及其风险因素和干预措施的地图。
PLoS One. 2024 Feb 27;19(2):e0297775. doi: 10.1371/journal.pone.0297775. eCollection 2024.
9
Estimating the global impact of rotavirus vaccines on child mortality.估算轮状病毒疫苗对儿童死亡率的全球影响。
Int J Infect Dis. 2023 Dec;137:90-97. doi: 10.1016/j.ijid.2023.10.005. Epub 2023 Oct 18.
10
Rotavirus vaccine product switch in Ghana: An assessment of service delivery costs, switching costs, and cost-effectiveness.加纳轮状病毒疫苗产品转换:服务提供成本、转换成本及成本效益评估
PLOS Glob Public Health. 2023 Aug 9;3(8):e0001328. doi: 10.1371/journal.pgph.0001328. eCollection 2023.
轮状病毒疫苗加强针有进一步降低腹泻死亡率的潜力。
Vaccine. 2017 Dec 18;35(51):7198-7203. doi: 10.1016/j.vaccine.2017.10.027. Epub 2017 Nov 20.
4
Estimating global, regional and national rotavirus deaths in children aged <5 years: Current approaches, new analyses and proposed improvements.估算全球、区域和国家5岁以下儿童轮状病毒死亡人数:当前方法、新分析及拟议改进措施
PLoS One. 2017 Sep 11;12(9):e0183392. doi: 10.1371/journal.pone.0183392. eCollection 2017.
5
Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.儿童对轮状病毒感染和胃肠炎的自然获得性免疫:出生队列研究的配对再分析
J Infect Dis. 2017 Aug 1;216(3):317-326. doi: 10.1093/infdis/jix310.
6
The rotavirus vaccine development pipeline.轮状病毒疫苗研发管线。
Vaccine. 2019 Nov 28;37(50):7328-7335. doi: 10.1016/j.vaccine.2017.03.076. Epub 2017 Apr 7.
7
A Systematic Review of the Effect of Rotavirus Vaccination on Diarrhea Outcomes Among Children Younger Than 5 Years.轮状病毒疫苗对5岁以下儿童腹泻结局影响的系统评价
Pediatr Infect Dis J. 2016 Sep;35(9):992-8. doi: 10.1097/INF.0000000000001232.
8
In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13.2007/08 年至 2012/13 年,12 个欧洲国家在常规疫苗接种前,轮状病毒基因型分布和感染年龄的季节性和非季节性变化。
Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30106.
9
Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED).发展中国家社区腹泻的病原体特异性负担:一项多地点出生队列研究(MAL-ED)
Lancet Glob Health. 2015 Sep;3(9):e564-75. doi: 10.1016/S2214-109X(15)00151-5. Epub 2015 Jul 19.
10
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.发展中国家婴幼儿腹泻疾病负担和病因学(全球肠道发病和生存研究,GEMS):一项前瞻性、病例对照研究。
Lancet. 2013 Jul 20;382(9888):209-22. doi: 10.1016/S0140-6736(13)60844-2. Epub 2013 May 14.